A Window into Schizophrenia: Evaluating Social Dysfunction Using Real-World Audio Recordings

了解精神分裂症的窗口:使用真实世界的录音评估社交功能障碍

基本信息

  • 批准号:
    9889187
  • 负责人:
  • 金额:
    $ 7.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2023-02-28
  • 项目状态:
    已结题

项目摘要

Project Summary Social dysfunction is among the most disabling aspects of schizophrenia. Because laboratory assessments are limited, social dysfunction is often measured in daily life. Two common approaches are ecological momentary assessment (EMA; subjective appraisals of one's environment) and mobile sensing methods (MSM; track real- world activity and proximity to speech). Although EMA and MSM increase ecological validity, neither obtains objective accounts of a core facet of social dysfunction: social interactions. The inability to objectively monitor real-world interactions is a critical barrier to accurately identifying and measuring social dysfunction in schizophrenia. The Electronically Activated Recorder (EAR), a computer application for widely used smartphone devices, passively captures real-world social interactions via audio recordings. This proposal's scientific premise is that the EAR will account for limitations of current methods by offering a novel tool to identify social dysfunction in real-world interactions. The specific aims are to determine the EAR's feasibility, replicability, construct validity, and incremental validity for measuring social dysfunction in schizophrenia. A secondary aim is to improve the EAR's efficiency for research and clinical use by reducing rating time. To test aims, objective ratings of social dysfunction will be made using EAR recordings at baseline and one-month time points in: 1) Healthy control (n = 50) and 2) Schizophrenia groups (n = 50). To show incremental validity, EAR, EMA, and MSM will be conducted simultaneously to test if the EAR accounts for variance beyond EMA/MSM in social dysfunction or its common covariates. In line with NIMH's mission, this proposal will transform understanding of a core mental illness component (i.e., social dysfunction) by offering a window into schizophrenia. Specifically, it addresses Strategic Objective 2.2 by applying a method to identify clinically useful behavioral indicators of social dysfunction. Further, this proposal's use of novel technology to collect real-time data on complex behaviors in schizophrenia is compatible with a recent NIMH High-Priority Area notice (NOT-MH-18-031). Following this study, an R01 trial will integrate the EAR with other naturalistic assessments to measure social dysfunction across illness stages. After the R01, future work will focus on fully automating the EAR and translating it to clinical practice; the long-term goal is to create an evidence-based, objective real-world assessment that evaluates social dysfunction efficiently and is sensitive to different stages of illness and recovery in schizophrenia. However, larger trials are not possible without this essential R03 phase, which serves as a necessary initial test of whether the EAR is feasible and yields added value beyond other real-world approaches.
Project Summary Social dysfunction is among the most disabling aspects of schizophrenia. Because laboratory assessments are limited, social dysfunction is often measured in daily life. Two common approaches are ecological momentary assessment (EMA; subjective appraisals of one's environment) and mobile sensing methods (MSM; track real- world activity and proximity to speech). Although EMA and MSM increase ecological validity, neither obtains objective accounts of a core facet of social dysfunction: social interactions. The inability to objectively monitor real-world interactions is a critical barrier to accurately identifying and measuring social dysfunction in schizophrenia. The Electronically Activated Recorder (EAR), a computer application for widely used smartphone devices, passively captures real-world social interactions via audio recordings. This proposal's scientific premise is that the EAR will account for limitations of current methods by offering a novel tool to identify social dysfunction in real-world interactions. The specific aims are to determine the EAR's feasibility, replicability, construct validity, and incremental validity for measuring social dysfunction in schizophrenia. A secondary aim is to improve the EAR's efficiency for research and clinical use by reducing rating time. To test aims, objective ratings of social dysfunction will be made using EAR recordings at baseline and one-month time points in: 1) Healthy control (n = 50) and 2) Schizophrenia groups (n = 50). To show incremental validity, EAR, EMA, and MSM will be conducted simultaneously to test if the EAR accounts for variance beyond EMA/MSM in social dysfunction or its common covariates. In line with NIMH's mission, this proposal will transform understanding of a core mental illness component (i.e., social dysfunction) by offering a window into schizophrenia. Specifically, it addresses Strategic Objective 2.2 by applying a method to identify clinically useful behavioral indicators of social dysfunction. Further, this proposal's use of novel technology to collect real-time data on complex behaviors in schizophrenia is compatible with a recent NIMH High-Priority Area notice (NOT-MH-18-031). Following this study, an R01 trial will integrate the EAR with other naturalistic assessments to measure social dysfunction across illness stages. After the R01, future work will focus on fully automating the EAR and translating it to clinical practice; the long-term goal is to create an evidence-based, objective real-world assessment that evaluates social dysfunction efficiently and is sensitive to different stages of illness and recovery in schizophrenia. However, larger trials are not possible without this essential R03 phase, which serves as a necessary initial test of whether the EAR is feasible and yields added value beyond other real-world approaches.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kyle S Minor其他文献

The impact of premorbid adjustment, neurocognition, and depression on social and role functioning in patients in an early psychosis treatment program
早期精神病治疗计划中病前调整、神经认知和抑郁对患者社会和角色功能的影响
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kyle S Minor;Michelle S. Friedman;Y Jude Leung;Eric C. Meyer;S. Zimmet;B. Caplan;Thomas F. Monteleone;Caitlin Bryant;Margaret E. Guyer;M. Keshavan;Larry J. Seidman
  • 通讯作者:
    Larry J. Seidman

Kyle S Minor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 7.53万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 7.53万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 7.53万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 7.53万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 7.53万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 7.53万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 7.53万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 7.53万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 7.53万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 7.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了